The data were, however, not compatible with a protective intention-to-treat effect. They concluded: Randomized trials using MALO as an outcome might be unfeasible, motivating further large observational studies using appropriate methodology to further delineate the effect of GLP1 agonists on the risk of MALO, complementing future phase 3 trials of GLP1 agonists.
BPC 157 , short for Body Protection Compound-157, is a 15-amino-acid peptide fragment associated with a protective protein found in human gastric juice
O'Sullivan JDB, Nicu C, Picard M, et al
Moreover, IV Energy improves the levels of vitamins and minerals which help regenerate cells and correct deficiencies such as: anemia, insomnia, electrolyte imbalances, stress and thyroid conditions, strengthening the bodys ability to take on daily challenges